Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice | Zendy

M. Youssef | Zendy; Elias Fattal | Zendy; Marı́a José Alonso | Zendy; L. Roblot-Treupel | Zendy; J. Sauzieres | Zendy; C Tancrède | Zendy; A Omnès | Zendy; Patrick Couvreur | Zendy; Antoine Andremont | Zendy

Open Access

Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice

Author(s) -

M. Youssef,

Elias Fattal,

Marı́a José Alonso,

L. Roblot-Treupel,

J. Sauzieres,

C Tancrède,

A Omnès,

Patrick Couvreur,

Antoine Andremont

Publication year - 1988

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.32.8.1204

Subject(s) - ampicillin , listeria monocytogenes , antibiotics , microbiology and biotechnology , chemistry , nanoparticle , listeria , biology , bacteria , materials science , nanotechnology , genetics

The effectiveness of nanoparticle-bound ampicillin was tested in the treatment of experimental Listeria monocytogenes infection in congenitally athymic nude mice. Nanoparticles of polyisohexylcyanoacrylate (PIHCA) 187 +/- 13 nm in diameter were bound to ampicillin at an ampicillin/PIHCA ratio of 0.2:1. The proportion of ampicillin bound was 90% +/- 3%. After adsorption onto nanoparticles, the therapeutic activity of ampicillin increased dramatically over that in the free state. Thus, 2.4 mg of nanoparticle-bound ampicillin (three doses of 0.8 mg each) had a greater therapeutic effect than 48 mg of free ampicillin (three doses of 16 mg each). These results might provide an incentive for further development of intracellular targeting of antibiotics on biodegradable polymeric carriers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research